TCW Group’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
TCW Group's NEO Position: Q1 2022 in Review
TCW Group sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 233,162 shares — an estimated $7.96M sold.
TCW Group first reported a position in NEO in Q3 2019 and held it in 10 quarters. The position peaked at $12.8M in Q3 2021. 279 funds tracked by Wall St. Rank hold NEO as of Q1 2022.
- TCW Group reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
- TCW Group sold 233,162 NeoGenomics shares in Q1 2022, an estimated $7.96M.
- TCW Group first reported a position in NeoGenomics in Q3 2019 and held it in 10 quarters.
- TCW Group's NeoGenomics position peaked at $12.8M in Q3 2021.
- 279 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.
Based on TCW Group's 13F filing for Q1 2022, filed 19 Apr 2022.